Jia Zhang

Jia Zhang

Auto-generated profile, based on publicly available information

Jia Zhang

National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Provincial Center for Regenerative Medicine and Surgical Engineering, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JBJianbin Bi
Jianbin Bi
LYLifei Yang
Lifei Yang
TWTao Wang
Tao Wang
JZJia Zhang
Jia Zhang
TLTeng Li
Teng Li
RWRongqian Wu
Rongqian Wu
An aged liver has decreased reparative capacity during ischemia-reperfusion (IR) injury. A recent study showed that plasma irisin levels predict telomere length in healthy adults. The aim of the present study is to clarify the role of irisin, telomerase activity, and autophagy during hepatic IR in the elderly. To study this, hepatic IR was established in 22-month- and 3-month-old rats and primary hepatocytes were isolated. The results showed that the old rats exhibited more serious liver injury and lower levels of irisin expression, telomerase activity, autophagy ability, and mitochondrial function than young rats during hepatic IR. Irisin activated autophagy and improved mitochondrial function via increasing telomerase activity in aged hepatocytes. Inhibition of telomerase activity by BIBP1532 abolished the protective role of irisin in hepatocytes during hypoxia and reoxygenation. Additionally, this study proved irisin increased the telomerase activity via inhibition of the phosphorylation of JNK during hepatic IR. Administration of exogenous irisin significantly mitigated the inflammation, oxidative stress, apoptosis, and liver injury in an old rat model of hepatic IR. In conclusion, irisin improves autophagy of aged hepatocytes via increasing telomerase activity in hepatic IR. Irisin exhibits conspicuous benefits in increasing reparative capacity of an aged liver during hepatic IR.

31 December 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
JZJia Zhang
Jia Zhang
MKMengyun Ke
Mengyun Ke
YRYifan Ren
Yifan Ren
JBJianbin Bi
Jianbin Bi
ZDZhaoqing Du
Zhaoqing Du
RWRongqian Wu
Rongqian Wu
Background. Hepatectomy remains one of the most effective treatments for patients with hepatocellular carcinoma (HCC); however, it can lead to serious complications. Irisin, a key regulator of energy metabolism, is secreted into the circulation by shedding of the extracellular portion of the fibronectin type III domain-containing 5 (FNDC5). We have shown that irisin administration alleviates liver ischemia-reperfusion injury in mice. However, the role of preoperative irisin levels in HCC patients who underwent hepatectomy remained unknown. The purpose of this study was to determine how irisin expression changes in HCC and to explore the relationship between preoperative serum irisin levels and complications after hepatectomy. Methods. FNDC5/irisin expression data in HCC were extracted from The Cancer Genome Atlas (TCGA) dataset. A total of 219 participants, including 102 healthy controls and 117 HCC patients, were recruited in this study. All HCC patients underwent hepatectomy at the First Affiliated Hospital of the Xi’an Jiaotong University. Preoperative serum irisin levels were measured by ELISA. Postoperative complications were assessed using the comprehensive complication index (CCI) score. The Pearson rank correlation coefficient was computed to assess the correlation between preoperative serum irisin levels and postoperative CCI scores. Results. In TCGA dataset, FNDC5/irisin expression was downregulated in HCC tissues (P<0.001). Similarly, serum irisin levels were decreased in HCC patients (P<0.001). Low preoperative serum irisin levels were significantly correlated with high CCI scores after hepatectomy. Conclusions. Irisin may be a novel serum biomarker in the diagnosis of HCC and a predictor of complications after hepatectomy.

26 November 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
XCXue Chen
Xue Chen
JBJianbin Bi
Jianbin Bi
JZJia Zhang
Jia Zhang
ZDZhaoqing Du
Zhaoqing Du
YRYifan Ren
Yifan Ren
RWRongqian Wu
Rongqian Wu
Background. Lactate has been widely used as a risk indicator of outcomes in critically ill patients due to its ready measurement and good predictive ability. However, the interconnections between lactate metabolism and glucose metabolism have not been sufficiently explored, yet. In this study, we aimed to investigate whether glucose levels could influence the predictive ability of lactate and design a more comprehensive strategy to assess the in-hospital mortality of critically ill patients. Methods. We analyzed the clinical data of 293 critically ill patients. The primary outcome was in-hospital mortality. The logistic regression analysis and the area under the receiver operating characteristic curve (AUROC) were applied to evaluate the predictive ability of lactate in association with glucose. Results. The lactate level showed significant association with in-hospital mortality, and its predictive ability was also comparable to other prognostic scores such as the SOFA score and APACHE II score. We further divided 293 patients into three groups based on glucose levels: low-glucose group (9 mmol/L). The lactate level was associated with in-hospital mortality in the low- and high- glucose groups, but not in the medium-glucose group, whereas the SOFA score and APACHE II score were associated with in-hospital mortality in all three glucose groups. The AUROC of lactate in the medium-glucose group was also the lowest among the three glucose groups, indicating a decrease in its predictive ability. Conclusions. Our findings demonstrated that the predictive ability of lactate to assess in-hospital mortality could be influenced by glucose levels. In the medium glucose level (i.e., 7-9 mmol/L), lactate was inadequate to predict in-hospital mortality and the SOFA score; the APACHE II score should be utilized as a complementation in order to obtain a more accurate prediction.

6 December 2014 in Blood
Verified
Journal Article
Open access
ZWZhao Wang
Zhao Wang
YWYini Wang
Yini Wang
WHWenqiu Huang
Wenqiu Huang
LHLiangding Hu
Liangding Hu
XCXinan Cen
Xinan Cen
LWLin Wu
Lin Wu
Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome. It occurs as a primary or acquired disorder in a condition of chaotic and uncontrolled immune system stimulation. Recent studies showed that HLH occurs not only in children, but also in adult. Here we presented the data gathered from Chinese HLH Workgroup in order to make further understanding about the disease. Methods: We performed a multi-center study involving 613 cases of HLH patients. We analyzed the clinical features, laboratory tests, diagnosis, treatments and clinical outcomes of them. All the date came from 46 hospitals, between Jan 2006 to June 2014. Results: The median age was 29 years old (Range 1 month to 82 years old). Forty-nine cases of them were primary HLH, 489 cases were acquired HLH and the other 75 case had unknown underlying disease. Among the acquired HLH group, 211 cases were malignancy-associated HLH (M-HLH),207 cases were infection- associated HLH (I-HLH), 58 cases were macrophage activation syndrome (MAS), 9 cases were associated with pregnancy, 3 patients developed HLH after autologous hematopoietic stem cell transplantation, and one case was associated with hemolytic anemia. Over ninety percent (93.3%) of the patients had hepatic function damage. We found significant difference in some diagnostic criteria among M-HLH, I-HLH and MAS group. The mean leukocytes was (9.50±8.46)×109/L, and the mean thrombocytes was (100.69±87.61)×109/L , which were significantly higher in MAS group than the other. The brain natriuretic peptide (BNP) was higher in patients with M-HLH (5477.31±6048.08 pg/ml). The aspartate aminotransferase (AST) was and bilirubin were significantly higher in patients with I-HLH. The median survival time of 613 cases is 7 months. Until now, 258 cases of patients were still survived, 297 cases were died, and the other was lost. We observed 45 cases who underwent allogenic hematopoietic stem cell transplantation (allo-HCT), including 22 cases of primary HLH, 12 cases of M-HLH, 8 cases of EBV-HLH and 3cases with unknown underlying disease. In these allo-HCT patients, 26 cases were achieved complete remission (CR), 12 cases died from transplantation related mortality (TRM), and the other died from tumor relapse or refractory EBV infection. The dead exhibited much higher level in bilirubin, lactate dehydrogenase (LDH), creatinine, and urea nitrogen. On the contrary, they had lower leukocytes and thrombocytes counts, and hypoalbuminemia. Thrombocytopenia and hypoalbuminemia play an important role in poor prognosis. Conclusion: HLH is not only a childhood disease but also occurs in adult. It associated with many underlying conditions. Lymphoma and EBV infection were two major causes of acquired HLH. Hepatic function damage is one of the most typical HLH clinical manifestations, and it tends to be more serious for patients with I-HLH. In addition, the blood cells of the patients with MAS may not reduce in the early phase; and the patients with M-HLH are easy to catch cardiac dysfunction. Acquired HLH is still a high mortality disease, and allo-HCT is one of the effective means of treatment for acquired HLH. Thrombocytopenia and hypoalbuminemia play an important role in poor prognosis.

1 March 2021 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
PDF file
MZmengxin zhang
mengxin zhang
HHHui Huang
Hui Huang
JZJia Zhang
Jia Zhang
RLRu Li
Ru Li
Objective: Diatomite is widely used in food safety, energy saving, environmental protection, health, biochemical and other fields because of its superior performance. With the help of CiteSpace software, this paper makes a visual analysis of all the literatures related to the adsorption of diatomite in HowNet database. Results: The number of published papers of related research in China is increasing year by year, and the number of published journals is relatively concentrated. There are many authors who have been engaged in related research for a long time, but there are too few research institutions, and the intensity of cooperation among research institutions is not high. Conclusion: This paper deeply explores the development process and research hotspot of diatomite in adsorption, in order to promote the application of diatomite in production and life, and provide reference research ideas for scholars.

27 September 2026 in Advanced Science
Verified
Journal Article
Open access
TWTao Wang
Tao Wang
CSChenghua Song
Chenghua Song
XHXin He
Xin He
MWMengzhou Wang
Mengzhou Wang
WLWuming Liu
Wuming Liu
RWRongqian Wu
Rongqian Wu
Iron homeostasis plays a critical role in the pathogenesis and therapeutic management of hepatocellular carcinoma (HCC). Magnetoreceptor (MagR), also known as iron‐sulfur cluster assembly protein 1 (ISCA1), is a conserved protein maintaining iron homeostasis, plays an undefined role in HCC. The present study aimed to elucidate MagR's functional involvement in HCC pathogenesis and sorafenib‐induced ferroptosis, and to explore its therapeutic potential for HCC. Pan‐cancer analyses showed that MagR was significantly upregulated in HCC tissues compared with normal liver tissues, accompanied with advanced stage and poor prognosis in patients. Functional experiments further demonstrated that MagR deficiency suppressed HCC cell proliferation, migration, and invasion while enhancing the sensitivity of these cells to sorafenib‐induced ferroptosis, whereas overexpression of MagR had opposite effects. Mechanistically, MagR promoted HCC progression by sustaining cellular iron homeostasis and preserving mitochondrial function, and mediated ferroptosis sensitivity of HCC cells via regulating intracellular iron accumulation. Notably, in vivo studies showed that MagR ablation not only attenuated the growth of HCC xenograft tumors but also potentiated the antitumor efficacy of sorafenib. Collectively, these findings identify MagR as a potential therapeutic target for HCC and establish that therapeutic strategies targeting MagR could optimize sorafenib‐based treatment regimens for this disease.